Chrysophanol

Chrysophanol is a naturally occurring anthraquinone compound found in rhubarb, aloe vera, and several traditional medicinal plants. It exerts its primary effects by modulating ATP synthesis, activating antioxidant enzyme pathways, and interfering with cancer cell proliferation signaling cascades.

Origin & History

Chrysophanol is a natural anthraquinone compound found in plants such as rhubarb (Rheum officinale), Aloe vera, and sorrel. It is commercially available through standard isolation techniques from plant sources, with a purity exceeding 98%.

Historical & Cultural Context

Chrysophanol is found in rhubarb, a component of traditional Chinese medicine known for its antimicrobial properties. Specific traditional roles of chrysophanol are not detailed in available sources.

Health Benefits

• May block colon cancer cell proliferation by reducing ATP levels and inducing necrosis (preclinical evidence) • Attenuates effects of lead exposure in mice, improving memory and learning (animal evidence) • Enhances antioxidant enzymes like SOD and GSH-Px, reducing oxidative stress (preclinical evidence) • Reduces neuronal edema and improves mitochondrial function in lead-exposed mice (animal evidence) • Suppresses EGFR and mTOR signaling pathways, potentially reducing cancer cell proliferation (in vitro/in vivo evidence)

How It Works

Chrysophanol disrupts mitochondrial ATP production in cancer cells, triggering necrotic cell death rather than apoptosis by depleting cellular energy reserves. It upregulates superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), key antioxidant enzymes that neutralize reactive oxygen species (ROS). Additionally, chrysophanol has been shown to inhibit NF-κB signaling and modulate acetylcholinesterase activity, which may underlie its neuroprotective effects observed in lead-exposure animal models.

Scientific Research

No human clinical trials, RCTs, or meta-analyses for chrysophanol are identified, with all evidence limited to in vitro and animal studies. Specific PMIDs are not provided in the research dossier.

Clinical Summary

The current evidence base for chrysophanol consists almost entirely of in vitro cell studies and rodent models, with no completed human clinical trials published as of early 2025. Animal studies using murine lead-exposure models demonstrated improvements in spatial memory and learning tasks alongside reduced hippocampal oxidative markers. Preclinical colon cancer research showed dose-dependent reductions in HCT116 and SW480 cell viability linked to ATP depletion and necrosis induction. While these findings are mechanistically promising, extrapolation to human therapeutic use is premature without Phase I or II trial data.

Nutritional Profile

Chrysophanol (CAS 481-74-3) is a naturally occurring anthraquinone compound (molecular formula: C15H10O4, molecular weight: 254.24 g/mol), not a conventional food nutrient and therefore carries no macronutrient, vitamin, or mineral profile. Bioactive compound classification: hydroxyanthraquinone derivative, specifically 1,8-dihydroxy-3-methylanthraquinone. Found in trace to moderate concentrations in rhubarb root (Rheum officinale, ~0.1–1.2 mg/g dry weight), Cassia species seeds (~0.5–2.0 mg/g dry weight), Polygonum multiflorum (~0.3–0.8 mg/g dry weight), and aloe latex (~0.05–0.3 mg/g dry weight). As an isolated compound it is not a source of calories, fiber, or protein. Key bioactive properties stem from its anthraquinone chromophore enabling redox activity and mitochondrial interaction. Oral bioavailability is limited due to poor water solubility (log P ~2.9), though intestinal absorption is facilitated by passive diffusion; first-pass metabolism produces glucuronide and sulfate conjugates. Peak plasma concentrations in animal studies reached approximately 50–200 ng/mL following oral doses of 20–50 mg/kg. Tissue distribution favors liver, kidney, and intestinal tissues. Half-life estimated at 4–8 hours in rodent models. No established dietary reference intake or therapeutic dosage range has been defined for humans. Primary bioactive mechanisms linked to ATP synthesis inhibition, antioxidant enzyme upregulation (SOD, GSH-Px), and mitochondrial membrane stabilization rather than nutritional contribution.

Preparation & Dosage

There are no clinically studied dosage ranges for chrysophanol due to the absence of human trials. Preclinical research uses stock solutions for models. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Curcumin, Quercetin, Resveratrol, Green Tea Extract, Vitamin C

Safety & Interactions

Chrysophanol belongs to the anthraquinone class, which as a group has been associated with laxative effects, electrolyte imbalances, and potential genotoxicity at high or prolonged doses, as documented with structurally related compounds like emodin. No human pharmacokinetic or toxicology studies specific to isolated chrysophanol have been published, making safe dosage thresholds undefined. It may theoretically interact with anticoagulants, chemotherapy agents, or drugs metabolized via CYP450 enzymes given its anthraquinone structure. Chrysophanol should be avoided during pregnancy and lactation due to the stimulant laxative potential of anthraquinones and complete absence of reproductive safety data.